SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Ligand (LGND) Breakout! -- Ignore unavailable to you. Want to Upgrade?

To: tonyt who wrote (22417)6/17/1998 8:19:00 PM
From: Proton  Read Replies (1) | Respond to of 32384
 
Re: Crashing the Violator's Ball, Are We?

Here's what Dow Jones had to say...Copyright (c) 1998 Dow Jones & Company, Inc. All Rights Reserved.

Which part of the verbiage after the ellipses do you and Henry not understand? In the process of feeding your insatiable (and inexplicable) desire to mock Niman, you have joined him in engaging in copyright infringement.

I won't say I couldn't care less, but you may both rest assured that I don't care enough to bring this to the attention of the copyright holders or SI's proprietors.

I am surprised Henry hasn't been given the big Red Card on this matter.

Pý



To: tonyt who wrote (22417)6/17/1998 8:23:00 PM
From: Mudcat  Read Replies (1) | Respond to of 32384
 
<Under FDA procedures, the review clock is suspended upon issuance of the review letter and is not reactivated until Seragen addresses all deficiencies.>

Doesn't appear to be much time left on the clock once it is reactivated.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News